PURPOSE: Ouabain, an Na+/K+-ATPase inhibitor hormone, presents immunomodulatory actions, including anti-inflammatory effect on acute inflammation models. METHODS: In the present study, the effect of ouabain in a model of allergic airway inflammation induced by ovalbumin (OVA) was assessed. RESULTS: Initially, it was observed that ouabain treatment inhibited cellular migration induced by OVA on bronchoalveolar lavage fluid (BALF), mostly granulocytes, without modulating macrophage migration. In addition, it was observed, by flow cytometry, that ouabain reduces CD3high lymphocytes cells on BALF. Furthermore, treatment with ouabain decreased IL-4 and IL-13 levels on BALF. Ouabain also promoted pulmonary histological alterations, including decreased cell migration into peribronchiolar and perivascular areas, and reduced mucus production in bronchioles regions observed through hematoxylin-eosin (HE) and by periodic acid-Schiff stain, respectively. Allergic airway inflammation is characterized by high OVA-specific IgE serum titer. This parameter was also reduced by the treatment with ouabain. CONCLUSIONS: Therefore, our data demonstrate that ouabain negatively modulates allergic airway inflammation induced by OVA.
PURPOSE:Ouabain, an Na+/K+-ATPase inhibitor hormone, presents immunomodulatory actions, including anti-inflammatory effect on acute inflammation models. METHODS: In the present study, the effect of ouabain in a model of allergic airway inflammation induced by ovalbumin (OVA) was assessed. RESULTS: Initially, it was observed that ouabain treatment inhibited cellular migration induced by OVA on bronchoalveolar lavage fluid (BALF), mostly granulocytes, without modulating macrophage migration. In addition, it was observed, by flow cytometry, that ouabain reduces CD3high lymphocytes cells on BALF. Furthermore, treatment with ouabain decreased IL-4 and IL-13 levels on BALF. Ouabain also promoted pulmonary histological alterations, including decreased cell migration into peribronchiolar and perivascular areas, and reduced mucus production in bronchioles regions observed through hematoxylin-eosin (HE) and by periodic acid-Schiff stain, respectively. Allergic airway inflammation is characterized by high OVA-specific IgE serum titer. This parameter was also reduced by the treatment with ouabain. CONCLUSIONS: Therefore, our data demonstrate that ouabain negatively modulates allergic airway inflammation induced by OVA.
Authors: J M Hamlyn; M P Blaustein; S Bova; D W DuCharme; D W Harris; F Mandel; W R Mathews; J H Ludens Journal: Proc Natl Acad Sci U S A Date: 1991-07-15 Impact factor: 11.205
Authors: Prescott G Woodruff; Barmak Modrek; David F Choy; Guiquan Jia; Alexander R Abbas; Almut Ellwanger; Laura L Koth; Joseph R Arron; John V Fahy Journal: Am J Respir Crit Care Med Date: 2009-05-29 Impact factor: 21.405
Authors: Rachel K Rosenstein; Jelena S Bezbradica; Shuang Yu; Ruslan Medzhitov Journal: Proc Natl Acad Sci U S A Date: 2014-11-04 Impact factor: 11.205
Authors: P L Jacob; J A Leite; A K A Alves; Y K S Rodrigues; F M Amorim; P L N Néris; M R Oliveira; S Rodrigues-Mascarenhas Journal: Parasitol Res Date: 2012-10-04 Impact factor: 2.289
Authors: Giciane C Vieira; Josenilson F De Lima; Regina C B Q De Figueiredo; Sandra R Mascarenhas; Claudio R Bezerra-Santos; Marcia R Piuvezam Journal: Phytother Res Date: 2012-08-30 Impact factor: 5.878
Authors: Sarah Rebeca Dantas Ferreira; Rayane Fernandes Pessoa; Indyra Alencar Duarte Figueiredo; João Pedro Moura Lima; Thayna Maria Costa Fernandes de Moura; Cleyton Oliveira Bezerra; Alissa Maria de Oliveira Martins; Leila Moreira de Carvalho; Marta Suely Madruga; Hassler Clementino Cavalcante; Jailane de Souza Aquino; José Luiz de Brito Alves; Adriano Francisco Alves; Luiz Henrique César Vasconcelos; Fabiana de Andrade Cavalcante Journal: Sci Rep Date: 2022-06-09 Impact factor: 4.996
Authors: Laércia K D Paiva Ferreira; Larissa A M Paiva Ferreira; Adriano Francisco Alves; Fagner Carvalho Leite; Luiz A de Araújo Silva; Giciane Carvalho Vieira; Luís Cezar Rodrigues; Marcia Regina Piuvezam Journal: Inflammation Date: 2018-12 Impact factor: 4.092
Authors: Luiz H A Cavalcante-Silva; Éssia de Almeida Lima; Deyse C M Carvalho; José M de Sales-Neto; Anne K de Abreu Alves; José G F M Galvão; Juliane S de França da Silva; Sandra Rodrigues-Mascarenhas Journal: Front Physiol Date: 2017-11-10 Impact factor: 4.566